RxDoctor Payments Data

Paul Duff

Medical · Jacksonville, FLNPI 1821092503

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 74.4% of it on its own, with 50 other manufacturers making up the rest. 2025 is the largest year on record at $10,866, 2.6 times the $4,230 reported in 2021. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,230in general payments, 2019–2025

Across 503 payments — averaging $70.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$26K
  • AbbVie$2K
  • Boston Scientific$1K
  • Abbott$969
  • Amgen$553
  • Tersera Therapeutics LLC$513
  • plus $4K from 45 others
$140in research payments, 2019–2025

Across 1 payment — averaging $140.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$140

What the payments were for

  • Speaking & faculty fees$13,77639%
  • Travel & lodging$6,40818%
  • Food & beverage$15,04643%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,230 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$116,966
Medicare patients
236
Services billed
1,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant22$33,385
MovantikNaloxegol Oxalate29$13,483
Lidocaine81$11,900
Emgality SyringeGalcanezumab-Gnlm13$9,238
Gabapentin455$6,589
Tizanidine Hcl319$5,417
Diclofenac Sodium85$3,220
Baclofen91$1,870
Cyclobenzaprine Hcl112$1,764
Methocarbamol114$1,604
Ibuprofen74$1,058
Chlorzoxazone13$866
Duloxetine Hcl60$825
Meloxicam84$411
Ondansetron Hcl20$236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$1,734$33,38522 claims
Redhill Biopharma Inc.Movantik$117$13,48329 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.

Other medical in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →